medicare semaglutide to Cover Weight-Loss Drug Wegovy for Certain Patients Medicare will negotiate Novo's GLP-1

Missing doses or stopping treatment early reduces results

Healthcare providers may consider: Bacterial culture if infection is suspected Temporary discontinuation of semaglutide to assess symptom resolution Referral to allergy/immunology for suspected hypersensitivity reactions For type 2 diabetes patients only, alternative GLP-1 receptor agonist formulations (such as oral semaglutide/Rybelsus) if injection site reactions are recurrent and problematic Patients with confirmed hypersensitivity to semaglutide should not continue the medication

Accessed June 5, 2017

What Is Ozempic Breasts

These medications mimic the effects of a hormone produced in the body that regulates blood sugar